Clarius Group LLC’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $552K | Sell |
1,418
-954
| -40% | -$371K | 0.03% | 232 |
|
2025
Q1 | $1.03M | Buy |
2,372
+558
| +31% | +$243K | 0.06% | 137 |
|
2024
Q4 | $669K | Sell |
1,814
-9
| -0.5% | -$3.32K | 0.05% | 171 |
|
2024
Q3 | $948K | Sell |
1,823
-56
| -3% | -$29.1K | 0.07% | 130 |
|
2024
Q2 | $1.02M | Sell |
1,879
-60
| -3% | -$32.5K | 0.07% | 115 |
|
2024
Q1 | $1.01M | Sell |
1,939
-278
| -13% | -$144K | 0.07% | 118 |
|
2023
Q4 | $1.05M | Sell |
2,217
-21
| -0.9% | -$9.9K | 0.09% | 119 |
|
2023
Q3 | $974K | Sell |
2,238
-656
| -23% | -$286K | 0.09% | 119 |
|
2023
Q2 | $1.29M | Buy |
2,894
+62
| +2% | +$27.5K | 0.1% | 109 |
|
2023
Q1 | $1.3M | Sell |
2,832
-47
| -2% | -$21.6K | 0.11% | 107 |
|
2022
Q4 | $1.48M | Buy |
2,879
+73
| +3% | +$37.5K | 0.13% | 93 |
|
2022
Q3 | $1.28M | Buy |
2,806
+60
| +2% | +$27.3K | 0.13% | 95 |
|
2022
Q2 | $1.33M | Buy |
2,746
+159
| +6% | +$76.7K | 0.13% | 101 |
|
2022
Q1 | $1.2M | Hold |
2,587
| – | – | 0.09% | 114 |
|
2021
Q4 | $1.2M | Buy |
2,587
+15
| +0.6% | +$6.95K | 0.09% | 114 |
|
2021
Q3 | $959K | Buy |
2,572
+78
| +3% | +$29.1K | 0.09% | 126 |
|
2021
Q2 | $952K | Sell |
2,494
-18
| -0.7% | -$6.87K | 0.09% | 125 |
|
2021
Q1 | $902K | Buy |
2,512
+409
| +19% | +$147K | 0.09% | 121 |
|
2020
Q4 | $675K | Buy |
2,103
+74
| +4% | +$23.8K | 0.07% | 134 |
|
2020
Q3 | $545K | Sell |
2,029
-274
| -12% | -$73.6K | 0.07% | 127 |
|
2020
Q2 | $606K | Buy |
2,303
+270
| +13% | +$71K | 0.08% | 116 |
|
2020
Q1 | $462K | Buy |
2,033
+304
| +18% | +$69.1K | 0.09% | 115 |
|
2019
Q4 | $521K | Sell |
1,729
-25
| -1% | -$7.53K | 0.08% | 122 |
|
2019
Q3 | $421K | Buy |
1,754
+606
| +53% | +$145K | 0.08% | 141 |
|
2019
Q2 | $324K | Sell |
1,148
-40
| -3% | -$11.3K | 0.07% | 156 |
|
2019
Q1 | $341K | Buy |
+1,188
| New | +$341K | 0.08% | 127 |
|
2018
Q3 | – | Sell |
-1,046
| Closed | -$249K | – | 127 |
|
2018
Q2 | $249K | Buy |
+1,046
| New | +$249K | 0.1% | 71 |
|